Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Ricardo Romiti, MD, PhD
University of São Paulo Brazil
São Paulo, Brazil
IPC Board Member

Ricardo Romiti, MD, Ph.D., is responsible for the Psoriasis unit at the Department of Dermatology of the University of São Paulo, Brazil, and works as a Clinical Professor of Dermatology also at the University of São Paulo. Having gained his medical degree from the Faculty of Medicine of the University of São Paulo, where he also completed his residency in the Department of Dermatology.

Professor Romiti is currently a Board member of the International Psoriasis Council, a member of GRAPPA and the Latin American Society of Psoriasis (SOLAPSO), and Editor of the Brazilian Consensus of Psoriasis of the Brazilian Society of Dermatology. Besides, he has authored or co-authored numerous papers published in national and international dermatology journals and is the Editor of five books with a focus on psoriasis.

Last Updated: Feb 23, 2022

Matias Maskin, MD
CEMIC University, at Buenos Aires
Buenos Aires, Argentina

Dr. Matias Maskin is Assistant Professor at the Section of Dermatology, Department of Medicine, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC) University, at Buenos Aires. He specializes in internal medicine and dermatology at the University of Buenos Aires and serves as Chief of Dermatology and Coordinator of the psoriasis section at the Instituto Universitario CEMIC. Dr. Maskin is a founding member of the Latin American Society of Psoriasis (SOLAPSO), is active in psoriasis education programs with SOLAPSO in Argentina, and is part of the SOLAPSO Biosimilars Consensus in Argentina. A member of IPC's Latin America working group, Dr. Maskin has authored national and international publications, has served as an investigator for many psoriasis clinical trials, and has participated in many national and international congress presentations pertaining to psoriasis.

Last Updated: Apr 14, 2022


Johann Gudjonsson, MD, PhD
University of Michigan
Ann Arbor, Michigan, United States
IPC Board Member

Dr. Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Skin Molecular Immunology at the University of Michigan. Dr. Gudjonsson graduated from the University of Iceland Medical School and completed his internship and dermatology residency training at the University of Michigan. In 2008, Dr. Gudjonsson joined the faculty of the University of Michigan Department of Dermatology. Dr. Gudjonsson sees general dermatology patients at the University of Michigan Taubman Center. Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis and other inflammatory diseases of the skin, with projects directed at improving the diagnosis and treatment of psoriasis. Dr. Gudjonsson is the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. He received the Young Investigator Award from the American Academy of Dermatology in 2007 and his work has earned several research awards, including from the American Skin Association, the Dermatology Foundation, Doris Duke Foundation and the NIH. He is a director of an NIH sponsored Skin Biology Research Center at Michigan, and a member of the American Society for Clinical Investigation (ASCI) and serves on the Board of Scientific Counselors to NIAMS.

Last Updated: Jan 26, 2022

Catherine Smith, MD
St John's Institute of Dermatology, Guys and St Thomas's Hospitals
London, England, United Kingdom
IPC Board Member

Catherine is Professor of Dermatology and Therapeutics and Consultant Dermatologist at St John’s Institute of Dermatology, Kings College London and Guys and St Thomas’ Hospital.  She co-directs the Skin Therapy Research Unit, and is also a lead clinician in national specialised services for adults with severe psoriasis. Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involve major national and international collaboration.  She also has a major interest in guideline development and implementation in the UK and Europe, with the aim of bringing research findings into clinical practice.

Last Updated: Jan 26, 2022

Fernando Valenzuela , MD
University of Chile
Santiago, Chile

Dr. Valenzuela is currently Associate Professor of Dermatology at the University of Chile in Santiago. He has received multiple awards from his medical school days to the present, in addition to working closely with Dr. Kim Papp in Probity Medical Research doing clinical trials. He is highly regarded by his colleagues in Latin America and attends all SOLAPSO and RADLA meetings where he is frequently featured as a main speaker. He has been working and publishing about tofacitinib, new agents in psoriasis, quality of life and comorbidities. He is the Chilean coordinator of Global Psoriasis Atlas, the President of 2022 RADLA and the Head of the Department of Dermatology at the University of Chile. He is active in the IPC Latin America working group and has been an IPC Councilor since 2015.

Last Updated: May 20, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.